accessibility menu, dialog, popup

UserName

Viewing profile as user:
Candida auris: A Global Threat Hiding in Plain Sight—Diagnostics, Resistance, and Clinical Fallout

Title: Candida auris: A Global Threat Hiding in Plain Sight—Diagnostics, Resistance, and Clinical Fallout

Date: January 15, 2026

Time: 01:00 PM ET

Presenters: Nathan Ledeboer

Candida auris: A Global Threat Hiding in Plain Sight—Diagnostics, Resistance, and Clinical Fallout

Effective Detection and Management Strategies

Candida auris has emerged as a globally significant multidrug-resistant fungal pathogen associated with high morbidity, mortality, and substantial infection-control challenges. Its ability to persist on environmental surfaces, cause healthcare-associated outbreaks, and exhibit resistance to multiple antifungal classes underscores the need for effective detection and management strategies.

This webinar will review the clinical implications of C. auris colonization and infection, highlighting the current understanding of transmission dynamics, risk factors, and patient outcomes. We will examine approaches to screening, including optimal body sites for specimen collection, the role of targeted versus universal screening in high-risk care settings, and the strengths and limitations of culture-based and molecular diagnostic methods.

Learning Objectives

This webinar will help you:

  • Describe the clinical significance of C. auris colonization and infection, including its epidemiology, transmission pathways, associated patient outcomes, and implications for healthcare systems
  • Evaluate current strategies for screening and identifying C. auris colonization, comparing specimen collection sites, culture-based methods, and molecular diagnostic approaches
  • Interpret antifungal susceptibility testing (AFST) results for C. auris, including awareness of method-specific considerations, resistance patterns, and available breakpoints or epidemiologic cutoff values
  • Apply laboratory findings to clinical and infection-prevention decision-making, integrating screening results and AFST data into patient management, outbreak containment, and facility-level control strategies

Presenters

Nathan Ledeboer

Nathan Ledeboer

Professor of Pathology & Laboratory Medicine and Chief of Clinical Pathology at the Medical College of Wisconsin and Associate Chief Medical Officer for Laboratory Services at Froedtert Health

As the director of medical and technical activities for laboratory services at the Medical College of Wisconsin and Froedtert Health, Dr. Ledeboer oversees new assay development and implementation, approves all testing performed in these laboratories, and consults with physician colleagues regarding diagnostic test selection and result interpretation.

More Webinars You Might Like